Armata Pharmaceuticals

(NYSEMKT) ARMP

Current Price$9.46

Market Cap$357.54M

Since IPO (2019)+110%

5 Year+132%

1 Year+592%

1 Month+17%

Armata Pharmaceuticals Financials at a Glance

Market Cap

$357.54M

Revenue (TTM)

$4.90M

Net Income (TTM)

$173.80M

EPS (TTM)

$-4.79

P/E Ratio

-2.04

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Price

$9.46

Volume

1,929

Open

$9.71

Price

$9.46

Volume

1,929

Open

$9.71

Previous Close

$9.76

Daily Range

$9.29 - $10.75

52-Week Range

$1.17 - $16.34

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Price

$9.46

Volume

1,929

Open

$9.71

Previous Close

$9.76

Daily Range

$9.29 - $10.75

52-Week Range

$1.17 - $16.34

ARMP News

Armata Posts 59 Percent Q2 Revenue Jump

Motley Fool Markets TeamAug 12, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Armata Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Deborah L. Birx, MD

Website

www.armatapharma.com

Headquarters

Marina del Rey, CA 90292, US

ARMP Financials

Key Financial Metrics (TTM)

Gross Margin

69%

Operating Margin

-6%

Net Income Margin

-35%

Return on Equity

Return on Capital

-46%

Return on Assets

-2%

Earnings Yield

-49.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$357.54M

Shares Outstanding

36.63M

Volume

1.93K

Avg. Volume

50.96K

Financials (TTM)

Gross Profit

$3.37M

Operating Income

$31.22M

EBITDA

$29.69M

Operating Cash Flow

$25.76M

Capital Expenditure

$542.00K

Free Cash Flow

$26.30M

Cash & ST Invst.

$8.69M

Total Debt

$288.02M

Armata Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.08M

-12.1%

Gross Profit

$667.00K

-22.0%

Gross Margin

61.47%

N/A

Market Cap

$357.54M

N/A

Market Cap/Employee

$5.96M

N/A

Employees

N/A

Net Income

$124.30M

-4880.7%

EBITDA

$6.94M

+10.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$279.33M

-138.3%

Accounts Receivable

$472.00K

-36.6%

Inventory

$0.00

N/A

Long Term Debt

$283.45M

+241.0%

Short Term Debt

$4.56M

-89.5%

Return on Assets

-2.26%

N/A

Return on Invested Capital

-45.96%

N/A

Free Cash Flow

$6.73M

+14.3%

Operating Cash Flow

$6.67M

+15.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GNFTGenfit S.A.

GNFTGenfit S.A.$8.95+4.07%

CDXSCodexis, Inc.

CDXSCodexis, Inc.$2.79-0.89%

NVCTNuvectis Pharma, Inc.

NVCTNuvectis Pharma, Inc.$8.59-1.15%

CCCCC4 Therapeutics, Inc.

CCCCC4 Therapeutics, Inc.$2.55-7.27%

OABIOmniAb, Inc.

OABIOmniAb, Inc.$1.36-2.50%

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$1.48+5.71%

IMDXInsight Molecular Diagnostics Inc.

IMDXInsight Molecular Diagnostics Inc.$3.99-5.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.52+0.11%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.17+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.50+0.01%

KALVKalVista Pharmaceuticals

KALVKalVista Pharmaceuticals$26.68+0.39%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.99-0.01%

AALAmerican Airlines Group

AALAmerican Airlines Group$11.27-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$53.40-0.01%

Questions About ARMP

What is the current price of Armata Pharmaceuticals?

Armata Pharmaceuticals is trading at $9.46 per share.

What is the 52-week range for Armata Pharmaceuticals?

Over the past 52 weeks, Armata Pharmaceuticals has traded between $1.17 and $16.34.

How much debt does Armata Pharmaceuticals have?

As of the most recent reporting period, Armata Pharmaceuticals reported total debt of $288.02M.

How much cash does Armata Pharmaceuticals have on hand?

Armata Pharmaceuticals reported $8.69M in cash and cash equivalents in its most recent financial results.

What is Armata Pharmaceuticals’s dividend yield?

Armata Pharmaceuticals does not currently have a dividend yield.

Armata Pharmaceuticals

Armata Pharmaceuticals Financials at a Glance

ARMP News

Armata Posts 59 Percent Q2 Revenue Jump

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Armata Pharmaceuticals

ARMP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Armata Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ARMP

What is the current price of Armata Pharmaceuticals?

What is the 52-week range for Armata Pharmaceuticals?

How much debt does Armata Pharmaceuticals have?

How much cash does Armata Pharmaceuticals have on hand?

What is Armata Pharmaceuticals’s dividend yield?

Premium Investing Services